Interní Med. 2005; 7(7): 349-353

CURRENT APPROACH TO THE FUNGAL PULMONARY INFECTIONS

MUDr. Roman Zazula Ph.D1, MUDr. Ivo Schindler2, MUDr. Antonín Spálený2, MUDr. Martina Vašáková2, MUDr. Juraj Dutka CSc3
1 Anesteziologicko-resuscitační oddělení, Fakultní Thomayerova nemocnice Praha
2 Anesteziologicko resuscitační klinika 1. LF UK a FTNsP Praha, Pneumologická klinika 1. LF UK a FTNsP Praha
3 FTN Praha, Chirurgická klinika

Mycoses rank among important and serious infections. With nosocomial infections, microscopic fungi are the inciting agent in up to 12 percent of cases. New antimycotics have remarkably improved the effects of their treatment, but mortality still remains threateningly high, above all with invasive mycotic diseases. The article summarises contemporary trends in the diagnosis and treatment of mycotic pulmonary infections.

Keywords: Key words: mycotic infections, pneumonia, diagnosis, therapy, antimycotics.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zazula R, Schindler I, Spálený A, Vašáková M, Dutka J. CURRENT APPROACH TO THE FUNGAL PULMONARY INFECTIONS. Interní Med. 2005;7(7):349-353.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Blumberg HM, et al. NEMIS Study Group Clin Infect Dis 2001; 33 (2): 177-186. Go to original source... Go to PubMed...
    2. Denning DW. Aspergillosis in, ,Nonimmunocompromised" Critically Ill Patiens, Am J Resp Crit Care Med 2004; 170: 580-581. Go to original source... Go to PubMed...
    3. Dimopoulos G, et al. Disseminated aspergillosis in intensive care unit patients: an autopsy study, J Chemother 2003; 15: 71-75. Go to original source... Go to PubMed...
    4. Haber J, et al. Stanovisko odborných společností k indikaci a použití antimykotik se systémovým účinkem, Anest intenziv Med 2005; 16, 1: 72-77.
    5. Haber J, et al. Systémové mykózy a jejich léčba, Galén, Praha, 1995.
    6. Herbrecht R, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis, NEJM 2002; 347: 408-415. Go to original source... Go to PubMed...
    7. Kao AS, et al. The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance, Clin Infect Dis 1999; 29: 1164. Go to original source... Go to PubMed...
    8. Kullberg BJ, Pappas P, Ruhnke M, et al. Voriconazole compared to a strategy of amphotericin B followed by fluconazole for treatment of candidaemia in non-neutropenic patients. 14th European Congress of Clinical Mikrobiology and Infectious Diseases, Prague June 2004, Abstrakt: M-1761.
    9. Meersseman W, et al. Invasive Aspergillosis in Critically Ill Patients without Malignancy, Am J Resp Crit Care Med 2004; 170; 621-625. Go to original source... Go to PubMed...
    10. Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. NEJM 2002; 347: 2020-2029. Go to original source... Go to PubMed...
    11. Novák I, Haber J. Rozhodovací algoritmy v léčbě invazivní mykotické infekce, Pfizer, 2004.
    12. Orgánové infekce způsobené mikroskopickými houbami, Farmakoterapeutické informace, měsíčník pro lékaře a farmaceuty, SÚKL 1998; 3-4: 1-3.
    13. Piarroux R, et al. Assessment of preemptive treatment to prezent severe candidiasis in critically ill surgical patiens, Crit Care Med 2004; 32, 12: 2443-2448. Go to original source... Go to PubMed...
    14. Pinto Pedro S. The CT Halo sign, Radiology 2004; 230: 109-110. Go to original source... Go to PubMed...
    15. Prokop M, Galanski M. Computed Tomography of the Body, Thieme Verlag Berlin 2003. Go to original source...
    16. Ševčík P, Skřičková J, Šrámek V, et al. Záněty plic v intenzivní medicíně, Galén, 2004.
    17. Viudes A, et al. Eur J Microbiol Infect Dis 2002; 21: 767-774. Go to original source... Go to PubMed...
    18. Walsh T, Sable C, De Pauw B, et al. A Randomized, Double-blind, Multicenter Trial of caspofungin (CAS) v. Liposomal Amphotericin B (LAMB) for Empirical Antifungal Therapy (EAFRx) of Persistently Fibrile Neutropenic (PFN) Patiens (Pt), 43rd ICAAC Abstracts, American Society for Mikrobiology, September 2003, page 477.
    19. Walsh TJ, Pappas P, Winston DJ, et al. Voriconazole compared with liposomal amphotericin B for empirical antifugal therapy in patients with neutropenia and persistent fever, NEJM 2002; 24; 346 (4): 225-234. Go to original source... Go to PubMed...
    20. Wierzbicka M, Nowa Medycyna- Pulmonologia IV zeszyt 100 4/2000.
    21. Wisplinghoff H, et al. Clin Infect Dis 2004; 39, 1: 309-317.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.